Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 691 AL 705

Pilot study of H₂ therapy in Parkinson's disease: a randomized double-blind placebo-controlled trial

Yoritaka A, Takanashi M, Hirayama M, Nakahara T, Ohta S, Hattori N.

Mov Disord. 2013 Jun;28(6):836-9. doi: 10.1002/mds.25375. Epub 2013 Feb 11.

Developing dopaminergic cell therapy for Parkinson's disease--give up or move forward?

Lindvall O.

Mov Disord. 2013 Mar;28(3):268-73. doi: 10.1002/mds.25378. Epub 2013 Feb 11.

L-dopa treatment duration versus Parkinson's disease progression: the dorsal-ventral divide

Belujon P, Grace AA.

Mov Disord. 2013 Feb;28(2):120-1. doi: 10.1002/mds.25334. Epub 2013 Feb 7.

Primary progressive aphasia with parkinsonism

Doherty KM, Rohrer JD, Lees AJ, Holton JL, Warren J.

Mov Disord. 2013 Jun;28(6):741-6. doi: 10.1002/mds.25341. Epub 2013 Feb 11.

Lewy body pathology in a patient with a homozygous parkin deletion

Miyakawa S, Ogino M, Funabe S, Uchino A, Shimo Y, Hattori N, Ichinoe M, Mikami T, Saegusa M, Nishiyama K, Mori H, Mizuno Y, Murayama S, Mochizuki H.

Mov Disord. 2013 Mar;28(3):388-91. doi: 10.1002/mds.25346. Epub 2013 Feb 11.

Pesticides and human chronic diseases: evidences, mechanisms, and perspectives

Mostafalou S, Abdollahi M.

Toxicol Appl Pharmacol. 2013 Apr 15;268(2):157-77. doi: 10.1016/j.taap.2013.01.025. Epub 2013 Feb 9.

Spiral drawing during self-rated dyskinesia is more impaired than during self-rated Off

Memedi M, Westin J, Nyholm D.

Parkinsonism Relat Disord. 2013 May;19(5):553-6. doi: 10.1016/j.parkreldis.2013.01.011. Epub 2013 Feb 9.

Zonisamide for seizures in Parkinson's disease with dementia

Tombini M, Pellegrino G, Di Pino G, Assenza G.

Seizure. 2013 May;22(4):324-5. doi: 10.1016/j.seizure.2013.01.011. Epub 2013 Feb 8.

Relationship between cognitive impairment and white-matter alteration in Parkinson's disease with dementia: tract-based spatial statistics and tract-specific analysis

Kamagata K, Motoi Y, Tomiyama H, Abe O, Ito K, Shimoji K, Suzuki M, Hori M, Nakanishi A, Sano T, Kuwatsuru R, Sasai K, Aoki S, Hattori N.

Eur Radiol. 2013 Jul;23(7):1946-55. doi: 10.1007/s00330-013-2775-4. Epub 2013 Feb 13.

Improvement in non-tachycardia-induced cardiac failure after radiofrequency catheter ablation in a child with a right-sided accessory pathway

Fukunaga H, Akimoto K, Furukawa T, Takahashi K, Kishiro M, Shimizu T, Kamiyama H, Sumitomo N.

Heart Vessels. 2013 Nov;28(6):802-7. doi: 10.1007/s00380-013-0322-5. Epub 2013 Feb 13.

The cerebellum in Parkinson's disease

Wu T, Hallett M.

Brain. 2013 Mar;136(Pt 3):696-709. doi: 10.1093/brain/aws360. Epub 2013 Feb 11.

α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?

Kiely AP, Asi YT, Kara E, Limousin P, Ling H, Lewis P, Proukakis C, Quinn N, Lees AJ, Hardy J, Revesz T, Houlden H, Holton JL.

Acta Neuropathol. 2013 May;125(5):753-69. doi: 10.1007/s00401-013-1096-7. Epub 2013 Feb 12.

AMPA receptor positive allosteric modulators: a patent review

Pirotte B, Francotte P, Goffin E, de Tullio P.

Expert Opin Ther Pat. 2013 May;23(5):615-28. doi: 10.1517/13543776.2013.770840. Epub 2013 Feb 13.

Neurostimulation for Parkinson's disease with early motor complications

Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Hälbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltête D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Krüger R, Pinsker MO, Amtage F, Régis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G; EARLYSTIM Study Group.

N Engl J Med. 2013 Feb 14;368(7):610-22. doi: 10.1056/NEJMoa1205158.

A second honeymoon for Parkinson's disease?

Tanner CM.

N Engl J Med. 2013 Feb 14;368(7):675-6. doi: 10.1056/NEJMe1214913.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias